EDGAR Filing Documents for 0001564590-20-056643

Form 8-K - Current report:

SEC Accession No. 0001564590-20-056643

Filing Date

2020-12-10

Accepted

2020-12-10 09:11:50

Documents

Period of Report

2020-12-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	mirm-8k_20201209.htm	8-K	49314
2	EX-99.1	mirm-ex991_11.htm	EX-99.1	704520
3	EX-99.2	mirm-ex992_9.htm	EX-99.2	113740
	Complete submission text file	0001564590-20-056643.txt		868876

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404

Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085

Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)